242 related articles for article (PubMed ID: 28929175)
1. TUSC3: functional duality of a cancer gene.
Vašíčková K; Horak P; Vaňhara P
Cell Mol Life Sci; 2018 Mar; 75(5):849-857. PubMed ID: 28929175
[TBL] [Abstract][Full Text] [Related]
2. TUSC3 loss alters the ER stress response and accelerates prostate cancer growth in vivo.
Horak P; Tomasich E; Vaňhara P; Kratochvílová K; Anees M; Marhold M; Lemberger CE; Gerschpacher M; Horvat R; Sibilia M; Pils D; Krainer M
Sci Rep; 2014 Jan; 4():3739. PubMed ID: 24435307
[TBL] [Abstract][Full Text] [Related]
3. Loss of the oligosaccharyl transferase subunit TUSC3 promotes proliferation and migration of ovarian cancer cells.
Vaňhara P; Horak P; Pils D; Anees M; Petz M; Gregor W; Zeillinger R; Krainer M
Int J Oncol; 2013 Apr; 42(4):1383-9. PubMed ID: 23404293
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor candidate 3 (TUSC3) prevents the epithelial-to-mesenchymal transition and inhibits tumor growth by modulating the endoplasmic reticulum stress response in ovarian cancer cells.
Kratochvílová K; Horak P; Ešner M; Souček K; Pils D; Anees M; Tomasich E; Dráfi F; Jurtíková V; Hampl A; Krainer M; Vaňhara P
Int J Cancer; 2015 Sep; 137(6):1330-40. PubMed ID: 25735931
[TBL] [Abstract][Full Text] [Related]
5. miRNA-mediated TUSC3 deficiency enhances UPR and ERAD to promote metastatic potential of NSCLC.
Jeon YJ; Kim T; Park D; Nuovo GJ; Rhee S; Joshi P; Lee BK; Jeong J; Suh SS; Grotzke JE; Kim SH; Song J; Sim H; Kim Y; Peng Y; Jeong Y; Garofalo M; Zanesi N; Kim J; Liang G; Nakano I; Cresswell P; Nana-Sinkam P; Cui R; Croce CM
Nat Commun; 2018 Nov; 9(1):5110. PubMed ID: 30504895
[TBL] [Abstract][Full Text] [Related]
6. TUSC3: a novel tumour suppressor gene and its functional implications.
Yu X; Zhai C; Fan Y; Zhang J; Liang N; Liu F; Cao L; Wang J; Du J
J Cell Mol Med; 2017 Sep; 21(9):1711-1718. PubMed ID: 28272772
[TBL] [Abstract][Full Text] [Related]
7. Tumour suppressor candidate 3 inhibits biological function and increases endoplasmic reticulum stress of melanoma cells WM451 by regulating AKT/GSK3-β/β-catenin pathway.
Wang S; Zhu W
Cell Biochem Funct; 2020 Jul; 38(5):604-612. PubMed ID: 32090352
[TBL] [Abstract][Full Text] [Related]
8. TUSC3 suppresses glioblastoma development by inhibiting Akt signaling.
Jiang Z; Guo M; Zhang X; Yao L; Shen J; Ma G; Liu L; Zhao L; Xie C; Liang H; Wang H; Zhu M; Hu L; Song Y; Shen H; Lin Z
Tumour Biol; 2016 Sep; 37(9):12039-12047. PubMed ID: 27177902
[TBL] [Abstract][Full Text] [Related]
9. Decreased TUSC3 Promotes Pancreatic Cancer Proliferation, Invasion and Metastasis.
Fan X; Zhang X; Shen J; Zhao H; Yu X; Chen Y; Zhuang Z; Deng X; Feng H; Wang Y; Peng L
PLoS One; 2016; 11(2):e0149028. PubMed ID: 26871953
[TBL] [Abstract][Full Text] [Related]
10. TUSC3 induces drug resistance and cellular stemness via Hedgehog signaling pathway in colorectal cancer.
Ren Y; Deng R; Cai R; Lu X; Luo Y; Wang Z; Zhu Y; Yin M; Ding Y; Lin J
Carcinogenesis; 2020 Dec; 41(12):1755-1766. PubMed ID: 32338281
[TBL] [Abstract][Full Text] [Related]
11. Methylation status of TUSC3 is a prognostic factor in ovarian cancer.
Pils D; Horak P; Vanhara P; Anees M; Petz M; Alfanz A; Gugerell A; Wittinger M; Gleiss A; Auner V; Tong D; Zeillinger R; Braicu EI; Sehouli J; Krainer M
Cancer; 2013 Mar; 119(5):946-54. PubMed ID: 23096450
[TBL] [Abstract][Full Text] [Related]
12. Homozygous deletion in TUSC3 causing syndromic intellectual disability: a new patient.
Loddo S; Parisi V; Doccini V; Filippi T; Bernardini L; Brovedani P; Ricci F; Novelli A; Battaglia A
Am J Med Genet A; 2013 Aug; 161A(8):2084-7. PubMed ID: 23825019
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of substrate specificity of human oligosaccharyl transferase subunit N33/Tusc3 and its role in regulating protein N-glycosylation.
Mohorko E; Owen RL; Malojčić G; Brozzo MS; Aebi M; Glockshuber R
Structure; 2014 Apr; 22(4):590-601. PubMed ID: 24685145
[TBL] [Abstract][Full Text] [Related]
14. Decreased Tumor Suppressor Candidate 3 Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma.
Yu X; Zhang J; Zhong H; Liu F; Liang N; Wang Y; Meng X; Du J
Int J Med Sci; 2016; 13(12):963-969. PubMed ID: 27994502
[TBL] [Abstract][Full Text] [Related]
15. A defect in the TUSC3 gene is associated with autosomal recessive mental retardation.
Garshasbi M; Hadavi V; Habibi H; Kahrizi K; Kariminejad R; Behjati F; Tzschach A; Najmabadi H; Ropers HH; Kuss AW
Am J Hum Genet; 2008 May; 82(5):1158-64. PubMed ID: 18452889
[TBL] [Abstract][Full Text] [Related]
16. TUSC3 accelerates cancer growth and induces epithelial-mesenchymal transition by upregulating claudin-1 in non-small-cell lung cancer cells.
Feng S; Zhai J; Lu D; Lin J; Dong X; Liu X; Wu H; Roden AC; Brandi G; Tavolari S; Bille A; Cai K
Exp Cell Res; 2018 Dec; 373(1-2):44-56. PubMed ID: 30098333
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic function of TUSC3 in non-small cell lung cancer is associated with Hedgehog signalling pathway.
Gu Y; Pei X; Ren Y; Cai K; Guo K; Chen J; Qin W; Lin M; Wang Q; Tang N; Cheng Z; Ding Y; Lin J
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1749-1760. PubMed ID: 28487226
[TBL] [Abstract][Full Text] [Related]
18. SOX2 regulates multiple malignant processes of breast cancer development through the SOX2/miR-181a-5p, miR-30e-5p/TUSC3 axis.
Liu K; Xie F; Gao A; Zhang R; Zhang L; Xiao Z; Hu Q; Huang W; Huang Q; Lin B; Zhu J; Wang H; Que J; Lan X
Mol Cancer; 2017 Mar; 16(1):62. PubMed ID: 28288641
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic silencing of tumor suppressor candidate 3 confers adverse prognosis in early colorectal cancer.
Burgermeister E; Höde P; Betge J; Gutting T; Merkel A; Wu W; Tänzer M; Mossner M; Nowak D; Magdeburg J; Rückert F; Sticht C; Breitkopf-Heinlein K; Schulte N; Härtel N; Belle S; Post S; Gaiser T; Heppner BI; Behrens HM; Röcken C; Ebert MPA
Oncotarget; 2017 Oct; 8(49):84714-84728. PubMed ID: 29156678
[TBL] [Abstract][Full Text] [Related]
20. miR-873-5p inhibits the progression of colon cancer via repression of tumor suppressor candidate 3/AKT signaling.
Zhu Y; Zhang X; Qi M; Zhang Y; Ding F
J Gastroenterol Hepatol; 2019 Dec; 34(12):2126-2134. PubMed ID: 31039290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
